SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-074363
Filing Date
2022-06-24
Accepted
2022-06-24 17:01:27
Documents
12
Period of Report
2022-06-22
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2219233d1_8k.htm   iXBRL 8-K 23946
  Complete submission text file 0001104659-22-074363.txt   198955

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ptpi-20220622.xsd EX-101.SCH 3045
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptpi-20220622_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptpi-20220622_pre.xml EX-101.PRE 22603
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2219233d1_8k_htm.xml XML 3730
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

IRS No.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39752 | Film No.: 221040828
SIC: 2834 Pharmaceutical Preparations